Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nuclear pore complex interacting protein pseudogene (ENSG00000235705) is a DNA sequence on human chromosome 10 resembling functional NPIP family genes but lacking the ability to produce a functional protein[3][7]. Pseudogenes typically arise from duplication or retrotransposition events followed by mutation, rendering them nonfunctional[4][2]. Although rare pseudogenes may exhibit regulatory effects at the RNA level, NPIP pseudogenes (including ENSG00000235705) are generally classified as nonfunctional genetic elements and should not be considered as drug targets or key molecules in cellular signaling[2][6][4]. In summary, although it shares high sequence similarity with functional NPIP genes involved in nuclear pore complex biology, ENSG00000235705 does not encode an active protein and is not considered a valid molecular target for drug development or disease intervention[2][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein pseudogene (NPIP pseudogene).